The gut microbiome and ageing trajectories: mechanisms and clinical implications

IF 39.1 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Andrea Ticinesi, Stefania Maggi, Antonio Nouvenne, Giovanni Zuliani, Claudio Franceschi
{"title":"The gut microbiome and ageing trajectories: mechanisms and clinical implications","authors":"Andrea Ticinesi, Stefania Maggi, Antonio Nouvenne, Giovanni Zuliani, Claudio Franceschi","doi":"10.1038/s41574-026-01236-x","DOIUrl":null,"url":null,"abstract":"This Review discusses the current state of knowledge on the contribution of the gut microbiome as a potential key actor in defining how we age. The gut microbiome is a complex ecosystem that establishes lifelong dynamic interactions with the host at multiple levels (several gut–organ axes), differently influencing ageing patterns and age-related disease onset and progression across populations. Accordingly, the definition of a ‘normative’ gut microbiome remains elusive, depending largely on the interaction with the external environment. In this complex scenario, the causal role of the gut microbiome in defining the ageing trajectory and its precise contribution to various organ-specific age-related diseases is still uncertain in clinical terms and could be context specific. Multiparametric and uniqueness indexes within a given population have shown a certain capacity for predicting disability and mortality. However, the gut microbiome is shaped over time by exposure to different intrinsic and environmental factors, resulting in a high degree of inter-individual variability, a key phenomenon that should be considered to develop novel personalized strategies to counteract age-related disease and frailty. The gut microbiome varies highly between individuals and has a substantial contribution to long-term health. This Review examines the effect of the gut microbiome on ageing and frailty risk, including potential therapies to modify gut microbiome composition to promote healthy ageing.","PeriodicalId":18916,"journal":{"name":"Nature Reviews Endocrinology","volume":"22 6","pages":"323-337"},"PeriodicalIF":39.1000,"publicationDate":"2026-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41574-026-01236-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

This Review discusses the current state of knowledge on the contribution of the gut microbiome as a potential key actor in defining how we age. The gut microbiome is a complex ecosystem that establishes lifelong dynamic interactions with the host at multiple levels (several gut–organ axes), differently influencing ageing patterns and age-related disease onset and progression across populations. Accordingly, the definition of a ‘normative’ gut microbiome remains elusive, depending largely on the interaction with the external environment. In this complex scenario, the causal role of the gut microbiome in defining the ageing trajectory and its precise contribution to various organ-specific age-related diseases is still uncertain in clinical terms and could be context specific. Multiparametric and uniqueness indexes within a given population have shown a certain capacity for predicting disability and mortality. However, the gut microbiome is shaped over time by exposure to different intrinsic and environmental factors, resulting in a high degree of inter-individual variability, a key phenomenon that should be considered to develop novel personalized strategies to counteract age-related disease and frailty. The gut microbiome varies highly between individuals and has a substantial contribution to long-term health. This Review examines the effect of the gut microbiome on ageing and frailty risk, including potential therapies to modify gut microbiome composition to promote healthy ageing.

Abstract Image

肠道微生物组和衰老轨迹:机制和临床意义。
这篇综述讨论了肠道微生物群作为决定我们如何衰老的潜在关键因素的贡献的知识现状。肠道微生物群是一个复杂的生态系统,在多个层面(多个肠道器官轴)与宿主建立终身动态相互作用,不同地影响人群的衰老模式和年龄相关疾病的发生和进展。因此,“规范”肠道微生物组的定义仍然难以捉摸,主要取决于与外部环境的相互作用。在这种复杂的情况下,肠道微生物组在定义衰老轨迹中的因果作用及其对各种器官特异性年龄相关疾病的精确贡献在临床方面仍然不确定,可能是特定环境的。给定种群内的多参数和唯一性指标显示出一定的预测残疾和死亡率的能力。然而,随着时间的推移,肠道微生物群是通过暴露于不同的内在和环境因素而形成的,导致高度的个体间差异,这是一个关键现象,应该考虑开发新的个性化策略来对抗与年龄相关的疾病和虚弱。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nature Reviews Endocrinology
Nature Reviews Endocrinology 医学-内分泌学与代谢
CiteScore
42.00
自引率
0.70%
发文量
158
审稿时长
6-12 weeks
期刊介绍: Nature Reviews Endocrinology aspires to be the foremost platform for reviews and commentaries catering to the scientific communities it serves. The journal aims to publish articles characterized by authority, accessibility, and clarity, enhanced with easily understandable figures, tables, and other visual aids. The goal is to offer an unparalleled service to authors, referees, and readers, striving to maximize the usefulness and impact of each article. Nature Reviews Endocrinology publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians in the fields of endocrinology and metabolism. Its broad scope ensures that the work it publishes reaches the widest possible audience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书